Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Learn more about Moneysupermarket Group from CEO Peter Duffy in a video
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Peter Duffy is Chief Executive Officer at Moneysupermarket.Com Group PLC.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Dieter Sand, CEO of Arlandastad Group: Insights and Future Goals at Future Week | Dieter Sand, CEO, Arlandastad Group AB.
00:10:00
American Rare Earths CEO Highlights Major US Rare Earth Projects and Upcoming NASDAQ Listing
00:10:00
Dave Peacock's Strategy at Advantage Solutions | DAVE PEACOCK - Chief Executive Officer of Advantage Solutions
00:10:00
Choosing a Financial Planner: Key Criteria, Fees, and Next Steps
00:10:00
Laurent Junique, CEO of TDCX, discusses the outsourced customer experience (CX) market on #NYSEFloorTalk.
00:10:00
Unbound Group's Strategic Vision and Financial Outlook with Ian Watson and Dan Lampard | Ian Watson, CEO, Unbound Group PLC.
00:10:00
Greenbrier CEO Talks Manufacturing and Southern Border Challenges on 'The Exchange | Lorie L. Tekorius - Chief Executive Officer & President of The Greenbrier Companies
00:10:00
AJ Bell Reviews Lazard Emerging Markets Fund with Ryan Hughes
00:10:00
Protecting Assets from Catastrophic Illness and Medicaid Spend Down | Dave Gner, Founder, Legacy Financial Strategies, Inc.
00:10:00
Green Bonds Series: Investing in Social and Sustainability Bonds
00:10:00
Demystifying Impact Investing: Insights from Tom Mitchell |Tom Mitchell, Managing Director, Cambridge Associates LLC.
00:10:00
Star Diamond's Orion South Project Advances with Major Resource Boost